Skip to Main Content
Back to News

New Analyst Forecast: $EMR Given 'Equal-Weight' Rating

None

We just received data on a new analyst forecast for $EMR. Barclays gave a rating of 'Equal-Weight' for $EMR.

$EMR Analyst Ratings

Wall Street analysts have issued reports on $EMR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citigroup issued a "Buy" rating on 07/14/2025
  • B of A Securities issued a "Buy" rating on 07/02/2025
  • Keybanc issued a "Overweight" rating on 07/01/2025
  • Wells Fargo issued a "Overweight" rating on 07/01/2025
  • RBC Capital issued a "Outperform" rating on 05/08/2025

To track analyst ratings and price targets for $EMR, check out Quiver Quantitative's $EMR forecast page.

$EMR Price Targets

Multiple analysts have issued price targets for $EMR recently. We have seen 9 analysts offer price targets for $EMR in the last 6 months, with a median target of $145.0.

Here are some recent targets:

  • Julian Mitchell from Barclays set a target price of $127.0 on 08/07/2025
  • Tommy Moll from Stephens & Co. set a target price of $145.0 on 07/16/2025
  • Andrew Kaplowitz from Citigroup set a target price of $165.0 on 07/14/2025
  • Andrew Obin from B of A Securities set a target price of $155.0 on 07/02/2025
  • Ken Newman from Keybanc set a target price of $155.0 on 07/01/2025
  • Joseph O'Dea from Wells Fargo set a target price of $150.0 on 07/01/2025
  • Stephen Tusa from JP Morgan set a target price of $133.0 on 05/16/2025

$EMR Congressional Stock Trading

Members of Congress have traded $EMR stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$EMR Insider Trading Activity

$EMR insiders have traded $EMR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:

  • MICHAEL H. TRAIN (SVP & Chief Sustain Officer) sold 28,305 shares for an estimated $3,380,749
  • SURENDRALAL LANCA KARSANBHAI (President & CEO) sold 16,698 shares for an estimated $1,892,384
  • MARK A BLINN has made 0 purchases and 2 sales selling 1,887 shares for an estimated $237,205.
  • MATTHEW S LEVATICH sold 1,867 shares for an estimated $233,472

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$EMR Hedge Fund Activity

We have seen 860 institutional investors add shares of $EMR stock to their portfolio, and 1,011 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles